ArticleHeart and vessels2026
Association between resting heart rate and clinical outcomes in heart failure with preserved ejection fraction: age stratified insights from the KUNIUMI Registry.
Article in Heart and vessels, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Resting heart rate (HR) is a modifiable prognostic marker in heart failure (HF) with reduced ejection fraction, but its relevance in HF with preserved ejection fraction (HFpEF), especially among the very elderly, remains unclear. We aimed to evaluate the prognostic impact of elevated resting HR in HFpEF patients aged 80 years or older and compare it with those younger than 80 years. We prospectively studied 1,109 HFpEF patients from a total of 1,646 consecutive HF patients in the KUNIUMI Registry chronic cohort. Elevated HR was defined as resting HR of 70 beats per minute or more. The primary endpoint was a composite of cardiovascular death and HF hospitalization over a mean follow up of 1.77 ± 0.53 years. Among HFpEF patients in sinus rhythm (SR) aged below 80 years, HR of 70 beats per minute or more was significantly associated with worse cardiovascular outcomes (log rank P < 0.01). However, this association was attenuated in those aged 80 years or older in SR (log rank P = 0.11), and in patients with atrial fibrillation (AF), regardless of age. Elevated HR was independently associated with adverse outcomes in patients aged below 80 years in SR but not in those aged 80 years or older in SR. In conclusion, elevated resting HR is associated with adverse cardiovascular outcomes in HFpEF patients aged below 80 years in SR, but not in those aged 80 years or older or in those with AF. Age and rhythm specific approaches may be warranted in HFpEF management.
Indexed as
Identifiers
41936669What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.